Amendment ASA1-AB862

AB862-ASA1,6 Section 6. 51.4228 of the statutes is created to read:

AB862-ASA1,4,4 51.4228 Opioid settlement moneys. To obtain any moneys under s. 165.12 (2) (d), the department, or any other person or entity that submits an application on behalf of the state, shall submit to the joint committee on finance a proposed application describing the purpose and amounts for the proposed expenditure of settlement moneys that it proposes to submit to the corporation organized under s. 165.12 (2). If the cochairpersons of the joint committee on finance do not notify the department or person or entity within 14 working days after the date of the submittal of the application under this section that the committee has scheduled a meeting for the purpose of reviewing the proposed application, the department or person or entity may submit the application to the corporation organized under s. 165.12 (2) as proposed. If, within 14 working days after the date of the submittal of the proposed application under this section, the cochairpersons of the committee notify the department or person or entity that the committee has scheduled a meeting for the purpose of reviewing the proposed application, the department or person or entity may submit the proposed application only upon approval by the committee.

AB862-ASA1,7 Section 7. 165.12 of the statutes is created to read:

AB862-ASA1,4,14 165.12 Opioid settlement. (1) (a) If all of the following are satisfied, the attorney general may cooperate with local governments who are parties in the proceedings titled In re: National Prescription Opiate Litigation, Case No.: MDL 2804, in entering into a settlement agreement of legal or equitable claims of the state and local governments regarding opioids with any person or entity that engages in or has engaged in the manufacture, marketing, promotion, distribution, or dispensing of an opioid product, including but not limited to any persons or entities named as defendants in the court proceeding titled In re: National Prescription Opiate Litigation, Case No.: MDL 2804:

AB862-ASA1,4,16 1. The attorney general submits the proposed settlement agreement to the joint committee on finance.

AB862-ASA1,4,18 2. The proposed settlement agreement submitted under subd. 1. includes all of the following:

AB862-ASA1,4,20 a. The total amount of proceeds to be received by the corporation organized under sub. (2).

AB862-ASA1,4,22 b. Identification of the net settlement proceeds allocated to the state under sub. (2) (d) 1.

AB862-ASA1,4,24 c. Identification of the amount of attorney fees payable as a result of the settlement.

AB862-ASA1,5,2 3. The joint committee on finance reviews the proposed settlement agreement as described in par. (b).

AB862-ASA1,5,15 (b) If the cochairpersons of the joint committee on finance do not notify the attorney general within 10 working days after the date of the submittal of the proposed settlement agreement under this subsection that the committee has scheduled a meeting for the purpose of reviewing the proposed settlement agreement, the attorney general is authorized to enter into the settlement agreement as proposed. If, within 10 working days after the date of the submittal of the proposed settlement agreement under this subsection, the cochairpersons of the committee notify the attorney general that the committee has scheduled a meeting for the purpose of reviewing the proposed settlement agreement, the attorney general is authorized to enter the proposed settlement agreement only upon approval by the committee. Notwithstanding s. 165.10, all proceeds under the proposed settlement agreement shall be paid to the corporation organized by the attorney general under sub. (2).

AB862-ASA1,5,24 (2) No later than July 1, 2020, the attorney general shall organize a nonstock, nonprofit corporation under ch. 181 for the purposes of administering, receiving, and distributing all proceeds received from a settlement of any legal or equitable claims regarding opioids with any person or entity that engages in or has engaged in the manufacture, marketing, promotion, distribution, or dispensing of an opioid product, including any persons or entities named as defendants in the proceeding titled In re: National Prescription Opiate Litigation, Case No.: MDL 2804. As a condition of administering or receiving the proceeds of a settlement described under this subsection, the corporation shall meet all of the following criteria:

AB862-ASA1,5,25 (a) The board of directors of the corporation is composed of all of the following:

AB862-ASA1,6,2 1. To represent the interests of the state, each of the following, or his or her designee:

AB862-ASA1,6,3 a. The attorney general.

AB862-ASA1,6,4 b. The majority leader of the senate.

AB862-ASA1,6,5 c. The minority leader of the senate.

AB862-ASA1,6,6 d. The governor.

AB862-ASA1,6,7 e. The speaker of the assembly.

AB862-ASA1,6,8 f. The minority leader of the assembly.

AB862-ASA1,6,10 2. To represent the interests of the department of health services, the state, and local governmental units, the secretary of health services, or his or her designee.

AB862-ASA1,6,13 3. To represent the interests of the hospitals, the state, and local governmental units, a nominee of the president of the Wisconsin Hospital Association, and with advice and consent of the senate appointed, for a 3-year term.

AB862-ASA1,6,16 4. To represent the interests of American Indian tribes or bands, a nominee of the board of directors of the Great Lakes Inter-Tribal Council, and with advice and consent of the senate appointed, for a 3-year term.

AB862-ASA1,6,19 5. To represent the interests of the counties of this state, 4 individuals nominated by the executive director of the Wisconsin Counties Association, and with advice and consent of the senate appointed, for staggered 3-year terms.

AB862-ASA1,6,23 6. To represent the interests of the populous counties of this state, 4 individuals whose nomination is agreed to unanimously by the Milwaukee County executive, the Dane County executive, and the Waukesha County executive, and with advice and consent of the senate appointed, for staggered 3-year terms.

AB862-ASA1,7,3 7. To represent the interests of the cities of this state, 2 individuals nominated by the executive director of the League of Wisconsin Municipalities, and with advice and consent of the senate appointed, for staggered 3-year terms.

AB862-ASA1,7,6 (b) 1. Any initial appointment and any vacancy in appointments under par. (a) 3. to 7. may be filled by provisional appointment by the nominating authority, subject to senate confirmation.

AB862-ASA1,7,8 2. Any individual appointed under par. (a) 3. to 7. shall continue in office until a successor is chosen and qualifies.

AB862-ASA1,7,10 (c) The corporation is subject to a financial audit by the legislative audit bureau under s. 13.94 (1) (dv).

AB862-ASA1,7,16 (d) The moneys received by the corporation related to a settlement of legal or equitable claims regarding opioids with any person or entity that engages in or has engaged in the manufacture, marketing, promotion, distribution, or dispensing of an opioid product, including any persons or entities named as defendants in the proceeding titled In re: National Prescription Opiate Litigation, Case No.: MDL 2804, are allocated as follows after taking into consideration par. (e):

AB862-ASA1,7,19 1. Fifteen percent of the moneys received by the corporation shall be allocated to the state. The corporation shall release these moneys to the department of health services upon application to the corporation by the department of health services.

AB862-ASA1,7,21 2. Fifteen percent of the moneys received by the corporation shall be allocated to the counties as determined by agreement of the counties.

AB862-ASA1,7,23 3. After taking into account subds. 1. and 2., the remaining proceeds shall be used in the manner determined by the board.

AB862-ASA1,8,2 (e) If attorney fees and costs have not been paid before the receipt of settlement proceeds under this subsection by the corporation, the board may consider an application for attorney fees and costs and may pay attorney fees and costs from the proceeds received by the corporation.

AB862-ASA1,8,6 (f) The articles of incorporation or bylaws of the corporation state that the corporation shall not have members and that a purpose of the corporation is to receive, invest, manage, and administer moneys for the purpose of abating the opioid epidemic.

AB862-ASA1,8,11 (g) Each board member shall serve as a fiduciary of the corporation, separate and distinct from any representational capacity of the entity or person nominating or appointing the board member. The board shall manage and invest moneys and conduct all matters of the corporation consistent with the responsibility as a fiduciary to the corporation.

AB862-ASA1,8,14 (h) Any moneys determined by the board of the corporation to require investment may be delivered to the investment board to be invested by the investment board under s. 25.17 (1) (kq).

AB862-ASA1,8,18 (i) The corporation complies with open meetings laws under subch. V of ch. 19 as if the corporation is a governmental body, as defined in s. 19.82 (1), and complies with open records law under subch. II of ch. 19 as if the corporation is an authority, as defined in s. 19.32 (1).

AB862-ASA1,8,23 (j) The corporation authorizes no expenditure of proceeds of opioid-related settlements unless the expenditure is in accordance with any applicable court order and the expenditure is either an actual and reasonable administrative expense or is included in a comprehensive abatement plan and is consistent with any of the following purposes:

AB862-ASA1,8,25 1. Supporting clinical and evidence-based research and treatment efforts in this state to prevent and remedy opioid addiction.

AB862-ASA1,9,2 2. Supporting cost-effective opioid prevention and cessation programs, including programs that do any of the following:

AB862-ASA1,9,4 a. Improve access to medications that have been proven to prevent or reverse an opioid overdose and support recovery.

AB862-ASA1,9,5 b. Support peer support specialists.

AB862-ASA1,9,7 c. Support screening, brief intervention, and referral to treatment services in hospitals and correctional facilities.

AB862-ASA1,9,8 d. Support access to crisis beds and residential treatment services.

AB862-ASA1,9,10 e. Expand and establish mobile crisis response systems and crisis stabilization centers.

AB862-ASA1,9,11 f. Enforce laws regarding opioid prescriptions and sales.

AB862-ASA1,9,14 g. Build provider capacity for an integrated medical home model that coordinates substance abuse treatment between regional providers that provide ongoing care.

AB862-ASA1,9,16 h. Generally mitigate the growing opioid crisis through treatment, harm reduction, education, training, and law enforcement.

AB862-ASA1,9,18 i. Support access to foster care and child protective services for children and families dealing with opioid addiction.

AB862-ASA1,9,21 j. Improve access to opioid use treatment for high-risk populations, including children and adolescents, pregnant women, and infants who have been exposed in utero to opioids.

AB862-ASA1,9,23 k. Improve the public health of the citizens of this state by addressing issues arising as a result of past, present, and future use of opioid pain medications.

AB862-ASA1,9,25 (k) Annually, the corporation submits to the attorney general, the cochairpersons of the joint committee on finance, and each county clerk a report describing the activities of the corporation, reporting any expenditures of the corporation, and reporting any outcomes achieved by the expenditure.

AB862-ASA1,10,4 (3) Nothing in this section shall alter any local government's right to pursue, litigate, or resolve its claims.

AB862-ASA1,8 Section 8. Nonstatutory provisions.

AB862-ASA1,10,8 (1) Notwithstanding s. 165.12 (2) (a) 5., the initial terms of the members under that subdivision shall be staggered so as to have one member's term expire in 2022, one member's term expire in 2023, and two members' terms expire in 2024.

AB862-ASA1,10,11 (2) Notwithstanding s. 165.12 (2) (a) 6., the initial terms of the members under that subdivision shall be staggered so as to have one member's term expire in 2022, one member's term expire in 2023, and two members' terms expire in 2024.

AB862-ASA1,10,14 (3) Notwithstanding s. 165.12 (2) (a) 7., the initial terms of the members under that subdivision shall be staggered so as to have one member's term expire in 2023 and one member's term expire in 2024.

AB862-ASA1,10,15 (End)